Literature DB >> 11831501

Cognitive performance of current methamphetamine and cocaine abusers.

Sara L Simon1, Catherine P Domier, Tiffanie Sim, Kimberly Richardson, Richard A Rawson, Walter Ling.   

Abstract

Forty currently using methamphetamine (MA) abusers, 40 currently using cocaine (COC) abusers, and 80 comparison participants who did not use psychostimulants received a cognitive battery and questionnaires covering medical history and stimulant use patterns. Forty comparison participants were matched to the 40 MA users on age, education, ethnicity, and gender. The other 40 comparison participants were matched to the cocaine users on the same variables. This design was chosen because there were significant differences in age and ethnicity between COC and MA users that precluded a direct comparison between the groups. The COC group was older and predominantly African American compared to the predominantly Caucasian MA group. When compared to their matched non-using control groups, both MA and COC abusers were impaired on cognitive measures, but the type and degree of impairments were somewhat different.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11831501     DOI: 10.1300/j069v21n01_06

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  77 in total

Review 1.  Cognitive enhancement as a treatment for drug addictions.

Authors:  Mehmet Sofuoglu; Elise E DeVito; Andrew J Waters; Kathleen M Carroll
Journal:  Neuropharmacology       Date:  2012-06-23       Impact factor: 5.250

Review 2.  Neurocognitive impairment and HIV risk factors: a reciprocal relationship.

Authors:  Pria Anand; Sandra A Springer; Michael M Copenhaver; Frederick L Altice
Journal:  AIDS Behav       Date:  2010-12

3.  Working memory deficits affect risky decision-making in methamphetamine users with attention-deficit/hyperactivity disorder.

Authors:  Nichole A Duarte; Steven Paul Woods; Alexandra Rooney; J Hampton Atkinson; Igor Grant
Journal:  J Psychiatr Res       Date:  2012-02-02       Impact factor: 4.791

4.  Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities.

Authors:  Linda Chang; Thomas Ernst; Oliver Speck; Charles S Grob
Journal:  Am J Psychiatry       Date:  2005-02       Impact factor: 18.112

5.  Profile of executive deficits in cocaine and heroin polysubstance users: common and differential effects on separate executive components.

Authors:  Antonio Verdejo-García; Miguel Pérez-García
Journal:  Psychopharmacology (Berl)       Date:  2006-11-29       Impact factor: 4.530

Review 6.  The need for speed: an update on methamphetamine addiction.

Authors:  Alasdair M Barr; William J Panenka; G William MacEwan; Allen E Thornton; Donna J Lang; William G Honer; Tania Lecomte
Journal:  J Psychiatry Neurosci       Date:  2006-09       Impact factor: 6.186

7.  Cocaine and Pavlovian fear conditioning: dose-effect analysis.

Authors:  Suzanne C Wood; Jonathan Fay; Jennifer R Sage; Stephan G Anagnostaras
Journal:  Behav Brain Res       Date:  2006-11-13       Impact factor: 3.332

8.  Neurocognitive functioning of individuals with schizophrenia: using and not using drugs.

Authors:  Amber L Bahorik; Christina E Newhill; Shaun M Eack
Journal:  Schizophr Bull       Date:  2013-07-24       Impact factor: 9.306

9.  Poor working memory and reduced blood pressure levels in concurrent users of khat and tobacco.

Authors:  Motohiro Nakajima; Richard Hoffman; Mustafa Al'Absi
Journal:  Nicotine Tob Res       Date:  2013-09-28       Impact factor: 4.244

10.  Methamphetamine compromises gap junctional communication in astrocytes and neurons.

Authors:  Paul Castellano; Chisom Nwagbo; Luis R Martinez; Eliseo A Eugenin
Journal:  J Neurochem       Date:  2016-04-18       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.